FCCC Faculty Publications

Young NA, Al-Saleem T. Diagnosis of lymphoma by fine-needle aspiration cytology using the revised European-American classification of lymphoid neoplasms. Cancer Cytopathology. 1999 Dec 25;87(6) :325-345.

Barbisan LF, Mello MLS, Russo J, Vidal BD. Apoptosis and catastrophic cell death in benzo a pyrene- transformed human breast epithelial cells. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 1999 Dec 16;431(1) :133-139.

Adams GP, Schier R. Generating improved single-chain Fv molecules for tumor targeting. Journal of Immunological Methods. 1999 Dec 10;231(1-2) :249-260.

Michie AM, Trop S, Wiest DL, Zuniga-Pflucker JC. Extracellular signal-regulated kinase (ERK) activation by the pre-T cell receptor in developing thymocytes in vivo. Journal of Experimental Medicine. 1999 Dec 6;190(11) :1647-1655.

Katz AK, Carrell HL, Afshar CE, Glusker JP, Desai D, Amin S. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine- derived carcinogenic nitrosaminoketone (NNK): Three-dimensional structure. Structural Chemistry. 1999 Dec;10(6) :439-443.

Cirillo LA, Zaret KS. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Molecular Cell. 1999 Dec;4(6) :961-969.

Bruner DW, Boyd CP. Assessing women's sexuality after cancer therapy: Checking assumptions with the focus group technique. Cancer Nursing. 1999 Dec;22(6) :438-447.

Sauter ER, Ehya H, Babb J, Diamandis E, Daly M, Klein-Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer. 1999 Dec;81(7) :1222-7.

Ozols RF. Chemotherapy for ovarian cancer. Semin Oncol. 1999 Dec;26(6 Suppl 18) :34-40.

Miller SM, Fang CY, Manne SL, Engstrom PF, Daly MB. Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecologic Oncology. 1999 Dec;75(3) :406-412.

Pass HI, Robinson BW, Testa JR, Carbone M. Emerging translational therapies for mesothelioma. Chest. 1999 Dec;116(6) :455S-460S.

Edwards RH, Wasik MA, Finan J, Rodriguez R, Moore J, Kamoun M, Rennert H, Bird J, Nowell PC, Salhany KE. Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia. American Journal of Clinical Pathology. 1999 Dec;112(6) :819-827.

Zeng H, Bain LJ, Belinsky MG, Kruh GD. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Research. 1999 Dec 1;59(23) :5964-5967.

O'Brien ML, Vulevic B, Freer S, Boyd J, Shen H, Tew KD. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. J Pharmacol Exp Ther. 1999 Dec;291(3) :1348-55.

Van Oss CJ, Naim JO, Costanzo PM, Giese RF, Wu W, Sorling AF. Impact of different asbestos species and other mineral particles on pulmonary pathogenesis. Clays and Clay Minerals. 1999 Dec;47(6) :697-707.

Miller SM, Buzaglo JS, Simms SL, Green V, Bales C, Mangan CE, Sedlacek TV. Monitoring styles in women at risk for cervical cancer: Implications for the framing of health-relevant messages. Annals of Behavioral Medicine. 1999 Win;21(1) :27-34.

Dangel J, Wagner-Costalas J, Bove B, Vanderveer L, Itzen M, Daly M, Godwin AK. Novel germline BRCA1 mutation (155del4) in an African American with early-onset breast cancer. Hum Mutat. 1999 Dec;14(6) :545.

Witzig TE, White CA, Wiseman GA, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DHS, Parker E, Grillo-Lopez AJ. Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma. Journal of Clinical Oncology. 1999 Dec;17(12) :3793-3803.

Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5) :1143-9.

Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5) :1219-25.

Jernstrom H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet. 1999 Nov 27;354(9193) :1846-1850.

Schaller S, Grandemange S, Shpakovski GV, Golemis EA, Kedinger C, Vigneron M. Interactions between the full complement of human RNA polymerase II subunits. Febs Letters. 1999 Nov 19;461(3) :253-257.

Matsumoto Y, Kim K, Hurwitz J, Gary R, Levin DS, Tomkinson AE, Park MS. Reconstitution of proliferating cell nuclear antigen-dependent repair of apurinic/apyrimidinic sites with purified human proteins. Journal of Biological Chemistry. 1999 Nov 19;274(47) :33703-33708.

Ranganathan S, Ciaccio PJ, Walsh ES, Tew KD. Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation. Gene. 1999 Nov 15;240(1) :149-155.

Coia LR, Gunderson LL, Haller D, Hoffman J, Mohiuddin M, Tepper JE, Berkey B, Owen JB, Hanks GE. Outcomes of patients receiving radiation for carcinoma of the rectum - Results of the 1988-1989 patterns of care study. Cancer. 1999 Nov 15;86(10) :1952-1958.

Coleman J, Eaton S, Merkel G, Skalka AM, Laue T. Characterization of the self association of avian sarcoma virus integrase by analytical ultracentrifugation. Journal of Biological Chemistry. 1999 Nov 12;274(46) :32842-32846.

Shan X, Wang L, Hoffmaster R, Kruger WD. Functional characterization of human methylenetetrahydrofolate reductase in Saccharomyces cerevisiae. J Biol Chem. 1999 Nov 12;274(46) :32613-8.

Taylor JC, Markham GD. The bifunctional active site of s-adenosylmethionine synthetase. Roles of the active site aspartates. J Biol Chem. 1999 Nov 12;274(46) :32909-14.

Wu GS, Burns TF, McDonald ER, Meng RD, Kao G, Muschel R, Yen T, El-Deiry WS. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. Oncogene. 1999 Nov 11;18(47) :6411-6418.

Abdollahi A, Bao R, Hamilton TC. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene. 1999 Nov 11;18(47) :6477-6487.

Zhang YZ, Gould KL, Dunbrack Rl Jr, Cheng H, Roder H, Golemis EA. The evolutionarily conserved Dim1 protein defines a novel branch of the thioredoxin fold superfamily. Physiol Genomics. 1999 Nov 11;1(3) :109-18.

Keefe R, Dave V, Allman D, Wiest D, Kappes DJ. Regulation of lineage commitment distinct from positive selection. Science. 1999 Nov 5;286(5442) :1149-1153.

Engstrom PF. A new era for cancer prevention and control research. Cancer Epidemiology Biomarkers & Prevention. 1999 Nov;8(11) :955-956.

Ozols RF. Chemotherapy for ovarian cancer: Beyond paclitaxel plus carboplatin. Cancer Journal from Scientific American. 1999 Nov-Dec;5(6) :336-338.

Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Vollmer R, Wilding G. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group. Journal of Clinical Oncology. 1999 Nov;17(11) :3461-3467.

Tomayko MM, Punt JA, Bolcavage JM, Levy SL, Allman DM, Cancro MP. Expression of the Bcl-2 family member A1 is developmentally regulated in T cells. International Immunology. 1999 Nov;11(11) :1753-1761.

Young NA, Al-Saleem T. Hematopathologists and cytopathologists: Enemies or allies?. Diagnostic Cytopathology. 1999 Nov;21(5) :305-306.

Evans AA, London WT. Hepatitis B vaccine and liver problems in US children less than 6 years old. Epidemiology. 1999 Nov;10(6) :790-791.

Held-Warmkessel J. How to care for men with prostate cancer. Nursing. 1999 Nov;29(11) :51-3.

Wilson PW, Arthur JW, Haymet ADJ. Ice premelting during differential scanning calorimetry. Biophysical Journal. 1999 Nov;77(5) :2850-2855.

Daly M. NCCN practice guidelines: Genetics/familial high-risk cancer screening. Oncology-New York. 1999 Nov;13(11A) :161-182.

Levy MH. NCCN task force report: Supportive and palliative care. Oncology-New York. 1999 Nov;13(11A) :517-522.

Behrend SW, Coia LR. Patterns of care in radiation oncology. Semin Oncol Nurs. 1999 Nov;15(4) :303-12.

Gui M, Wiest DL, Li J, Kappes D, Hardy RR, Hayakawa K. Peripheral CD4(+) T cell maturation recognized by increased expression of Thy-1/CD90 bearing the 6C10 carbohydrate epitope. Journal of Immunology. 1999 Nov 1;163(9) :4796-4804.

Amoroso AR, Alpaugh RK, Barth MW, McCall AM, Weiner LM. Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII. Cancer Immunology Immunotherapy. 1999 Nov;48(8) :443-455.

Pehrson JR, Litwin S, Myers CB, Cohen LH. Pyrimidine dimer formation as a probe of nucleosome cove and linker structure in situ. Methods-a Companion to Methods in Enzymology. 1999 Nov;19(3) :447-456.

Nicolaou N. Radiation therapy treatment planning and delivery. Semin Oncol Nurs. 1999 Nov;15(4) :260-9.

Adler V, Yin ZM, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene. 1999 Nov 1;18(45) :6104-6111.

Guo ZW, Gallo JM. Selective Protection of 2',2'-Difluorodeoxycytidine (Gemcitabine). J Org Chem. 1999 Oct 29;64(22) :8319-8322.

Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology. 1999 Oct 22;53(7) :1384-1390.

Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ, George DL. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene. 1999 Oct 21;18(43) :5954-5958.

Frankenberg N, Jahn D, Jaffe EK. Pseudomonas aeruginosa contains a novel type V porphobilinogen synthase with no required catalytic metal ions. Biochemistry. 1999 Oct 19;38(42) :13976-13982.

Lubkowski J, Dauter Z, Yang F, Alexandratos J, Merkel G, Skalka AM, Wlodawer A. Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant. Biochemistry. 1999 Oct 12;38(41) :13512-13522.

Bosma GC, Chang Y, Karasuyama H, Bosma MJ. Differential effect of an Ig mu transgene on development of pre-B cells in fetal and adult SCID mice. Proceedings of the National Academy of Sciences of the United States of America. 1999 Oct 12;96(21) :11952-11957.

Zitzmann N, Mehta AS, Carrouee S, Butters TD, Platt FM, McCauley J, Blumberg BS, Dwek RA, Block TM. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti- hepatitis virus agents. Proceedings of the National Academy of Sciences of the United States of America. 1999 Oct 12;96(21) :11878-11882.

Law SF, Zhang YZ, Fashena SJ, Toby G, Estojak J, Golemis EA. Dimerization of the docking/adaptor protein HEF1 via a carboxy- terminal helix-loop-helix domain. Experimental Cell Research. 1999 Oct 10;252(1) :224-235.

Zekri ARN, Bahnassi AA, Bove B, Huang YJ, Russo IH, Rogatko A, Shaarawy S, Shawki OA, Hamza MR, Omer S, Khaled HM, Russo J. Allelic instability as a predictor of survival in Egyptian breast cancer patients. International Journal of Oncology. 1999 Oct;15(4) :757-767.

Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJP, Cheffetz S, Herlyn M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Research. 1999 Oct 1;59(19) :4876-4881.

Segal DM, Weiner GJ, Weiner LM. Bispecific antibodies in cancer therapy. Current Opinion in Immunology. 1999 Oct;11(5) :558-562.

Garay CA, Al-Saleem T, Testa JR, Smith MR. Coexisting myelodysplasia and myeloproliferative features in a single clone containing 5q-, Ph and i(17q). Leukemia Research. 1999 Oct;23(10) :965-967.

Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A, Godwin AK. Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Research. 1999 Oct 1;59(19) :4973-4983.

Park SH, Shastry MC, Roder H. Folding dynamics of the B1 domain of protein G explored by ultrarapid mixing. Nat Struct Biol. 1999 Oct;6(10) :943-7.

Yang X, Tahin Q, Hu YF, Russo IH, Balsara BR, Mihaila D, Slater C, Barrett JC, Russo J. Functional roles of chromosomes 11 and 17 in the transformation of human breast epithelial cells in vitro. Int J Oncol. 1999 Oct;15(4) :629-38.

Langer CJ. Induction or neoadjuvant therapy in resectable non-small cell lung cancer. Seminars in Oncology. 1999 Oct;26(5) :34-39.

Roder H, Shastry MR. Methods for exploring early events in protein folding. Curr Opin Struct Biol. 1999 Oct;9(5) :620-6.

Weiner LM. Monoclonal antibody therapy of cancer. Seminars in Oncology. 1999 Oct;26(5) :43-51.

Williams RW, Angel JM, Holdener BC, Oakey R, Hunter KW. Mouse Chromosome 7. Mammalian Genome. 1999 Oct;10(10) :947-947.

Wiseman GA, White CA, Witzig TE, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DHS, Grillo-Lopez AJ. Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a Y-90-labeled anti-CD20 monoclonal antibody. Clinical Cancer Research. 1999 Oct;5(10) :3281S-3286S.

Socinski MA, Langer CJ. Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer. Seminars in Oncology. 1999 Oct;26(5) :51-61.

Ershoff DH, Quinn VP, Boyd NR, Stern J, Gregory M, Wirtschafter D. The Kaiser Permanente prenatal smoking-cessation trial - When more isn't better, what is enough?. American Journal of Preventive Medicine. 1999 Oct;17(3) :161-168.

Battista S, Fidanza V, Fedele M, Klein-Szanto AJP, Outwater E, Brunner H, Santoro M, Croce CM, Fusco A. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Research. 1999 Oct 1;59(19) :4793-4797.

Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, George DL. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes & Development. 1999 Oct 1;13(19) :2490-2501.

Hudes G, Einhorn L, Ross E, Balsham A, Loehrer P, Ramsey H, Sprandio J, Entmacher M, Dugan W, Ansari R, Monaco F, Hanna M, Roth B. Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase network phase III trial. Journal of Clinical Oncology. 1999 Oct;17(10) :3160-3166.

Chan GK, Jablonski SA, Sudakin V, Hittle JC, Yen TJ. Human BUBR1 is a mitotic checkpoint kinase that monitors CENP-E functions at kinetochores and binds the cyclosome/APC. J Cell Biol. 1999 Sep 6;146(5) :941-54.

Brard F, Shannon M, Prak EL, Litwin S, Weigert M. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. Journal of Experimental Medicine. 1999 Sep 6;190(5) :691-704.

George P, Siegbahn PEM, Glusker JP, Bock CW. The dehydration step in the enzyme-coenzyme-B-12 catalyzed diol dehydrase reaction of 1,2-dihydroxyethane utilizing a hydrogen- bonded carboxylic acid group as an additional cofactor: A computational study. Journal of Physical Chemistry B. 1999 Sep 2;103(35) :7531-7541.

Tester WJ, Kim KM, Krigel RL, Bonomi PD, Glick JH, Asbury RF, Kirkwood JM, Blum RH, Schiller JH. A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer - An Eastern Cooperative Oncology Group study (PZ586). Lung Cancer. 1999 Sep;25(3) :199-206.

Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Journal of the National Cancer Institute. 1999 Sep 1;91(17) :1475-1479.

Chernoff J. Close encounters of the LIM-kinase. Nature Cell Biology. 1999 Sep;1(5) :E115-E117.

Houts PS, Hermann JF. Educational needs related to complementary and alternative therapies. Cancer Practice. 1999 Sep-Oct;7(5) :262-265.

Shen H, Schultz MP, Tew KD. Glutathione conjugate interactions with DNA-dependent protein kinase. J Pharmacol Exp Ther. 1999 Sep;290(3) :1101-6.

Frucht H, Jensen RT, Dexter D, Yang WL, Xiao Y. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin Cancer Res. 1999 Sep;5(9) :2532-9.

Srivastava P, Russo J, Russo IH. Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin. Molecular Carcinogenesis. 1999 Sep;26(1) :10-19.

Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C, Godwin A, Moslehi R, Olipade O, Brunet JS, Stickeler E, Kieback DG, Kreienberg R, Weber B, Narod SA, Runnebaum IB. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. British Journal of Cancer. 1999 Sep;81(1) :179-183.

Ross EA, Moore D. Modeling clustered, discrete, or grouped time survival data with covariates. Biometrics. 1999 Sep;55(3) :813-9.

Alpaugh K, von Mehren M. Monoclonal Antibodies in Cancer Treatment: A Review of Recent Progress. BioDrugs. 1999 Sep;12(3) :209-236.

Pui JC, Allman D, Xu LW, DeRocco S, Karnell FG, Bakkour S, Lee JY, Kadesch T, Hardy RR, Aster JC, Pear WS. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 1999 Sep;11(3) :299-308.

Stevenson JP, DeMaria D, Reilly D, Purvis JD, Graham MA, Lockwood G, Drozd M, O'Dwyer PJ. Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule. Cancer Chemotherapy and Pharmacology. 1999 Sep;44(3) :228-234.

Sells MA. Pictures in cell biology. Pak1 kinase activity affects the character of cell morphology and movement. Trends Cell Biol. 1999 Sep;9(9) :355.

Kaufmann RA, Padmore RF, Ridge JA, Friedman CD. Primary extraosseous cemento-ossifying fibroma of the auricle. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 1999 Sep;21(6) :578-581.

Sweed MR. Shedding light on sarcoidosis. Office Nurse.. 1999 Sep-Oct;12(7) :22-4.

Carleton M, Ruetsch NR, Berger MA, Rhodes M, Kaptik S, Wiest DL. Signals transduced by CD3 epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro. Journal of Immunology. 1999 Sep 1;163(5) :2576-2585.

Diefenbach MA, Miller SM, Daly MB. Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychology. 1999 Sep;18(5) :532-536.

Megee PC, Mistrot C, Guacci V, Koshland D. The centromeric sister chromatid cohesion site directs Mcd1p binding to adjacent sequences. Molecular Cell. 1999 Sep;4(3) :445-450.

Moraleda G, Seeholzer S, Bichko V, Dunbrack R, Otto J, Taylor J. Unique properties of the large antigen of hepatitis delta virus. Journal of Virology. 1999 Sep;73(9) :7147-7152.

Tseng M. Validation of dietary patterns assessed with a food-frequency questionnaire. American Journal of Clinical Nutrition. 1999 Sep;70(3) :422-422.

Hazelton DA, Hamilton TC. Vascular endothelial growth factor in ovarian cancer. Curr Oncol Rep. 1999 Sep;1(1) :59-63.

Bock CW, Katz AK, Markham GD, Glusker JP. Manganese as a replacement for magnesium and zinc: Functional comparison of the divalent ions. Journal of the American Chemical Society. 1999 Aug 18;121(32) :7360-7372.

Mehr R, Shannon M, Litwin S. Models for antigen receptor gene rearrangement. I. Biased receptor editing in B cells: Implications for allelic exclusion. Journal of Immunology. 1999 Aug 15;163(4) :1793-1798.

Piper H, Litwin S, Mehr R. Models for antigen receptor gene rearrangement. II. Multiple rearrangement in the TCR: Allelic exclusion or inclusion?. Journal of Immunology. 1999 Aug 15;163(4) :1799-1808.

Morgan RO, Jenkins NA, Gilbert DJ, Copeland NG, Balsara BR, Testa JR, Fernandez MP. Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution. Genomics. 1999 Aug 15;60(1) :40-49.

Yu W, Misulovin Z, Suh H, Hardy RR, Jankovic M, Yannoutsos N, Nussenzweig MC. Coordinate regulation of RAG1 and RAG2 by cell type-specific DNA elements 5 ' of RAG2. Science. 1999 Aug 13;285(5430) :1080-1084.

Weiner LM. An overview of monoclonal antibody therapy of cancer. Seminars in Oncology. 1999 Aug;26(4) :41-50.

Murthy SS, Testa JR. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. Journal of Cellular Physiology. 1999 Aug;180(2) :150-157.

Gudima S, Dingle K, Wu TT, Moraleda G, Taylor J. Characterization of the 5 ' ends for polyadenylated RNAs synthesized during the replication of hepatitis delta virus. Journal of Virology. 1999 Aug;73(8) :6533-6539.

Wiest DL, Berger MA, Carleton M. Control of early thymocyte development by the pre-T cell receptor complex: A receptor without a ligand?. Seminars in Immunology. 1999 Aug;11(4) :251-262.

Zhang CC, Yang JM, Bash-Babula J, White E, Murphy M, Levine AJ, Hait WN. DNA damage increases sensitivity to Vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. Cancer Research. 1999 Aug 1;59(15) :3663-3670.

Zhou T, Saputelli J, Aldrich CE, Deslauriers M, Condreay LD, Mason WS. Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine. Antimicrob Agents Chemother. 1999 Aug;43(8) :1947-54.

Watson JC, Sutanto-Ward E, Osaku M, Weinstein JK, Babb JS, Sigurdson ER. Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic metastases in BD-IX rats. Surgery. 1999 Aug;126(2) :358-63.

Markham GD, Bock CL, Trachtman M, Bock CW. Intramolecular nonbonded interactions between oxygen and group VIA elements: An ab initio molecular orbital and density functional theory investigation of the structures of HX-CH2- COOH (X = S, Se, and Te). Structural Chemistry. 1999 Aug;10(4) :263-276.

Manne SL. Intrusive thoughts and psychological distress among cancer patients: The role of spouse avoidance and criticism. Journal of Consulting and Clinical Psychology. 1999 Aug;67(4) :539-546.

Ozols RF. Oncology: current trends in the treatment of advanced ovarian cancer. Journal of Care Management.. 1999 Aug;5(4) :Disease Manage Digest: 6-7.

Chernoff J. Protein tyrosine phosphatases as negative regulators of mitogenic signaling. Journal of Cellular Physiology. 1999 Aug;180(2) :173-181.

Schilder R. Rituximab immunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 1999 Aug;14(4) :237-240.

Walker C, Ahmed SA, Brown T, Ho SM, Hodges L, Lucier G, Russo J, Weigel N, Weise T, Vandenbergh J. Species, interindividual, and tissue specificity in endocrine signaling. Environmental Health Perspectives. 1999 Aug;107 :619-624.

Miknyoczki SJ, Chang H, Klein-Szanto A, Dionne CA, Ruggeri BA. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma. Clinical Cancer Research. 1999 Aug;5(8) :2205-2212.

Gonen O, Wang ZJ, Viswanathan AK, Molloy PT, Zimmerman RA. Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1. AJNR Am J Neuroradiol. 1999 Aug;20(7) :1333-41.

Afshar CE, Katz AK, Carrell HL, Amin S, Desai D, Glusker JP. Three-dimensional structure of anti-5,6-dimethylchrysene-1,2- dihydrodiol-3,4-epoxide: a diol epoxide with a bay region methyl group. Carcinogenesis. 1999 Aug;20(8) :1549-1553.

Sonobe H, Takeuchi T, Liag SB, Taguchi T, Yuri K, Shimizu K, Iwata J, Furihata M, Ohtsuki Y, Testa JR. A new human synovial sarcoma cell line, HS-SY-3, with a truncated form of hybrid SYT/SSX1 gene. International Journal of Cancer. 1999 Jul 30;82(3) :459-464.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. International Journal of Radiation Oncology Biology Physics. 1999 Jul 15;44(5) :1005-1015.

Reczkowski RS, Markham GD. Slow binding inhibition of S-adenosylmethionine synthetase by imidophosphate analogues of an intermediate and product. Biochemistry. 1999 Jul 13;38(28) :9063-9068.

Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, Silver J, Hardy RR. Positive selection of natural autoreactive B cells. Science. 1999 Jul 2;285(5424) :113-116.

Savard J, Miller SM, Mills M, O'Leary A, Harding H, Douglas SD, Mangan CE, Belch R, Winokur A. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer. Psychosomatic Medicine. 1999 Jul-Aug;61(4) :496-507.

Fujio Y, Guo K, Mano T, Mitsuuchi Y, Testa JR, Walsh K. Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Molecular and Cellular Biology. 1999 Jul;19(7) :5073-5082.

Le Voyer TE, Hoffman JP, Cooper H, Ross E, Sigurdson E, Eisenberg B. Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment. Am Surg. 1999 Jul;65(7) :625-30; discussion 630-1.

Belinsky MG, Kruh GD. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer. 1999 Jul;80(9) :1342-9.

Schilder RJ, Johnson S, Gallo J, Kindsfather S, Rogers B, Bookman MA, Millenson MM, Boente M, Rosenblum N, Litwin S, Ozols RF. Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells. Journal of Clinical Oncology. 1999 Jul;17(7) :2198-2207.

Frank A, Montgomery RC, LeVoyer TE, Goldberg M. Pleural incarceration of the gastric graft after trans-hiatal esophagectomy. Annals of Thoracic Surgery. 1999 Jul;68(1) :250-252.

Fowble B. Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue. Seminars in Radiation Oncology. 1999 Jul;9(3) :230-240.

Freedman GM, Negendank WG, Hudes GR, Shaer AH, Hanks GE. Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer. Urology. 1999 Jul;54(1) :118-123.

Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology. 1999 Jul;54(1) :178-182.

Trop S, Steff AM, Denis F, Wiest DL, Hugo P. The connecting peptide domain of pT alpha dictates weak association of the pre-T cell receptor with the TCR zeta subunit. European Journal of Immunology. 1999 Jul;29(7) :2187-2196.

Iwamoto R, Fitzgibbons K, Langer CJ, Sarna L, Eisenberg P. Woman with lung cancer who continues to smoke. Cancer Practice. 1999 Jul-Aug;7(4) :165-169.

Yi J, Asante-Appiah E, Skalka AM. Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase. Biochemistry. 1999 Jun 29;38(26) :8458-68.

Serebriiskii I, Khazak V, Golemis EA. A two-hybrid dual bait system to discriminate specificity of protein interactions. Journal of Biological Chemistry. 1999 Jun 11;274(24) :17080-17087.

Apostolou S, De Rienzo A, Murthy SS, Jhanwar SC, Testa JR. Absence of BCL10 mutations in human malignant mesothelioma. Cell. 1999 Jun 11;97(6) :684-686.

Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomized trial of breast cancer risk counseling: The impact on self-reported mammography use. American Journal of Public Health. 1999 Jun;89(6) :924-926.

Rondinelli RH, Tricoli JV. CLAR1, a novel gene that exhibits enhanced expression in advanced human prostate cancer. Clinical Cancer Research. 1999 Jun;5(6) :1595-1602.

Campbell KS, Colonna M. DAP12: a key accessory protein for relaying signals by Natural Killer cell receptors. International Journal of Biochemistry & Cell Biology. 1999 Jun;31(6) :631-636.

Manne SL, Miller DL, Meyers P, Wollner N, Steinherz P, Redd WH. Difficulties completing treatment tasks among newly diagnosed children with cancer. Childrens Health Care. 1999 Sum;28(3) :255-276.

Tew KD, Ronai Z. GST function in drug and stress response. Drug Resist Updat. 1999 Jun;2(3) :143-147.

Shen XQ, Bubulya A, Zhou XF, Khazak V, Golemis EA, Shemshedini L. Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription. Endocrine. 1999 Jun;10(3) :281-289.

Jaiswal AK, Bell DW, Radjendirane V, Testa JR. Localization of human NQO1 gene to chromosome 16q22 and NQO2- 6p25 and associated polymorphisms. Pharmacogenetics. 1999 Jun;9(3) :413-418.

Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, Falkson G, Falkson HC, Taylor SG, Tormey DC. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. 1999 Jun;17(6) :1689-1700.

Le Voyer TE, Hunter KW. Microsatellite DNA variants among the FVB/NJ, C58/J, and I/LnJ mouse strains. Mamm Genome. 1999 Jun;10(6) :542-3.

Fowble B, Hanlon A, Freedman G, Patchefsky A, Kessler H, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Postmenopausal hormone replacement therapy: Effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. Journal of Clinical Oncology. 1999 Jun;17(6) :1680-1688.

Chapman JD, Anderson PR. Predicting and overcoming the radioresistance of individual tumors. International Journal of Radiation Oncology Biology Physics. 1999 Jun 1;44(3) :477-479.

Campbell KS. Signal transduction from the B cell antigen-receptor. Current Opinion in Immunology. 1999 Jun;11(3) :256-264.

Manne SL, Alfieri T, Taylor KL, Dougherty J. Spousal negative responses to cancer patients: The role of social restriction, spouse mood, and relationship satisfaction. Journal of Consulting and Clinical Psychology. 1999 Jun;67(3) :352-361.

Lin JH, Makris A, McMahon C, Bear SE, Patriotis C, Prasad VR, Brent R, Golemis EA, Tsichlis PN. The ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-1. Journal of Biological Chemistry. 1999 May 21;274(21) :14706-14715.

Kruh GD, Belinsky MG. Characterization of MOAT-C and MOAT-D, new members of the MRP cMOAT subfamily of transporter proteins - Response. Journal of the National Cancer Institute. 1999 May 19;91(10) :888-889.

Whalen EJ. Advanced practice. Complete care. Nursing. 1999 May 17;Spectrum(Greater Philadelphia/Tri-State Edition). 8(10) :13.

Sells MA, Boyd JT, Chernoff J. p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. Journal of Cell Biology. 1999 May 17;145(4) :837-849.

Dave VP, Allman D, Wiest DL, Kappes DJ. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection. Journal of Immunology. 1999 May 15;162(10) :5764-5774.

Walsh STR, Cheng H, Bryson JW, Roder H, DeGrado WF. Solution structure and dynamics of a de novo designed three- helix bundle protein. Proceedings of the National Academy of Sciences of the United States of America. 1999 May 11;96(10) :5486-5491.

Miknyoczki SJ, Lang D, Huang LY, Klein-Szanto AJP, Dionne CA, Ruggeri BA. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: Expression patterns and effects on in vitro invasive behavior. International Journal of Cancer. 1999 May 5;81(3) :417-427.

Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD. Radiation therapy for clinically localized prostate cancer - A multi-institutional pooled analysis. JAMA-Journal of the American Medical Association. 1999 May 5;281(17) :1598-1604.

Portenoy RK, Du Pen S, Ferrante FM, Hassenbusch SJ, Krames ES, Levy MH, Staats PS. A 15-year-old boy with primitive neurectodermal tumor. Oncology-New York. 1999 May;13(5) :20-24.

Portenoy RK, Du Pen S, Ferrante FM, Hassenbusch SJ, Krames E, Levy MH, Staats PS. A 38-year-old man with pancreatic cancer. Oncology-New York. 1999 May;13(5) :52-57.

Maurer BJ, Ihnat MA, Morgan C, Pullman J, O'Brien C, Johnson SW, Rasey JS, Cornwell MM. Growth of human tumor cells in macroporous microcarriers results in p53-independent, decreased cisplatin sensitivity relative to monolayers. Molecular Pharmacology. 1999 May;55(5) :938-947.

McCall AM, Adams GP, Amoroso AR, Nielsen UB, Zhang L, Horak E, Simmons H, Schier R, Marks JD, Weiner LM. Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis. Molecular Immunology. 1999 May;36(7) :433-445.

Rebbeck TR, Kantoff PN, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. American Journal of Human Genetics. 1999 May;64(5) :1371-1377.

Tew KD. Oxidants and antioxidants: outcome of prevention and treatment strategies. Biomedicine & Pharmacotherapy. 1999 May;53(4) :168-168.

Gate L, Paul J, Ba GN, Tew KD, Tapiero H. Oxidative stress induced in pathologies: the role of antioxidants. Biomedicine & Pharmacotherapy. 1999 May;53(4) :169-180.

Cooper KF, Mallory MJ, Strich R. Oxidative stress-induced destruction of the yeast C-type cyclin Ume3p requires phosphatidylinositol-specific phospholipase C and the 26S proteasome. Molecular and Cellular Biology. 1999 May;19(5) :3338-3348.

Levy MH. Pain control in patients with cancer. Oncology-New York. 1999 May;13(5) :9-14.

Cheng JD, Werness BA, Babb JS, Meropol NJ. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Clinical Cancer Research. 1999 May;5(5) :1057-1062.

Dresler CM, Fratelli C, Babb J. Prognostic value of positive pleural lavage in patients with lung cancer resection. Annals of Thoracic Surgery. 1999 May;67(5) :1435-1439.

Henske EP, Thorner P, Patterson K, Zhuang Z, Bernstein J. Renal cell carcinoma in children with diffuse cystic hyperplasia of the kidneys. Pediatr Dev Pathol. 1999 May-Jun;2(3) :270-4.

Matin TA, Goldberg M. Surgical staging of lung cancer. Oncology-New York. 1999 May;13(5) :679-685.

Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer Journal from Scientific American. 1999 May-Jun;5(3) :152-158.

Kruk PA, Godwin AK, Hamilton TC, Auersperg N. Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer. Gynecologic Oncology. 1999 May;73(2) :229-236.

Plank TL, Logginidou H, Klein-Szanto A, Henske EP. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Modern Pathology. 1999 May;12(5) :539-545.

Ozols R. Treatment of gynecologic cancer: The US experience. Tumori. 1999 May-Jun;85(3) :S5-S11.

Tricoli JV. Y chromosome enumeration in touch preparations from 42 prostate tumors by interphase fluorescence in situ hybridization analysis. Cancer Genetics and Cytogenetics. 1999 May;111(1) :1-6.

Daniel R, Katz RA, Skalka AM. A role for DNA-PK in retroviral DNA integration. Science. 1999 Apr 23;284(5414) :644-647.

Wagner T, Afshar CE, Carrell HL, Glusker JP, Englert U, Hogenkamp HPC. Difluoromethylcobalamin: Structural aspects of an old tree with a new branch. Inorganic Chemistry. 1999 Apr 19;38(8) :1785-1794.

Chang Y, Bosma MJ, Bosma GC. Extended duration of DH-JH rearrangement in immunoglobulin heavy chain transgenic mice: Implications for regulation of allelic exclusion. Journal of Experimental Medicine. 1999 Apr 19;189(8) :1295-1305.

Ferry KV, Fink D, Johnson SW, Nebel S, Hamilton TC, Howell SB. Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells. Biochemical Pharmacology. 1999 Apr 15;57(8) :861-867.

Iyer RV, Hanlon AL, Pinover WH, Hanks GE. Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy. Cancer. 1999 Apr 15;85(8) :1816-1821.

Mgbonyebi OP, Russo J, Russo IH. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Research. 1999 Apr 15;59(8) :1903-1910.

Hamilton TC. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. Journal of the National Cancer Institute. 1999 Apr 7;91(7) :650-650.

Markham GD, Bock CL, Schalk-Hihi C. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase. Biochemistry. 1999 Apr 6;38(14) :4433-4440.

Ashe JM, Wiest DL, Abe R, Singer A. ZAP-70 protein promotes tyrosine phosphorylation of T cell receptor signaling motifs (ITAMs) in immature CD4(+)8(+) thymocytes with limiting p56(lck). Journal of Experimental Medicine. 1999 Apr 5;189(7) :1163-1167.

Kelley DE, Stokes DG, Perry RP. CHD1 interacts with SSRP1 and depends on both its chromodomain and its ATPase/helicase-like domain for proper association with chromatin. Chromosoma. 1999 Apr;108(1) :10-25.

Manne S. Commentary: Well-established treatments for procedure-related pain: Issues for future research and policy implications. Journal of Pediatric Psychology. 1999 Apr;24(2) :147-149.

Azizogli MA, Catania EM, Weiner S. Comparison of the accuracy of working casts made by the direct and transfer coping procedures. Journal of Prosthetic Dentistry. 1999 Apr;81(4) :392-8.

Langer CJ. Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer. Seminars in Radiation Oncology. 1999 Apr;9(2) :108-116.

Chapman JD, Stobbe CC, Gales T, Das IJ, Zellmer DL, Biade S, Matsumoto Y. Condensed chromatin and cell inactivation by single-hit kinetics. Radiation Research. 1999 Apr;151(4) :433-441.

Daly M, Farmer J, Harrop-Stein C, Montgomery S, Itzen M, Costalas JW, Rogatko A, Miller S, Balshem A, Gillespie D. Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiology Biomarkers & Prevention. 1999 Apr;8(4) :393-398.

Hindmarsh P, Ridky T, Reeves R, Andrake M, Skalka AM, Leis J. HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. Journal of Virology. 1999 Apr;73(4) :2994-3003.

Liu SC, Hu Y, Sauter ER, Clapper ML, Chen SY, Lanfranchi HE, Engstrom PF, Klein-Szanto AJP. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa. Analytical and Quantitative Cytology and Histology. 1999 Apr;21(2) :166-173.

Loudon RP. Leukocyte chemoattractant chemokine receptors. Drug News & Perspectives. 1999 Apr;12(3) :147-156.

Focht SL. Lymphatic mapping and sentinel lymph node biopsy. AORN J. 1999 Apr;69(4) :802-9.

Tanisada K, Teshima T, Inoue T, Owen JB, Hanks GE, Abe M, Ikeda H, Sato S, Kawachi K, Yamashita T, Nishio M, Hiraoka M, Hirokawa Y, Oguchi M, Masuda K. National average for the process of radiation therapy in Japan by Patterns of Care Study. Japanese Journal of Clinical Oncology. 1999 Apr;29(4) :209-213.

Solin LJ, Schultz DJ, Hanchak NA, Kessler HB. Patterns of treatment for older women with newly diagnosed breast carcinoma. American Journal of Clinical Oncology-Cancer Clinical Trials. 1999 Apr;22(2) :107-113.

Manne S, Alfieri T, Taylor K, Dougherty J. Preferences for spousal support among individuals with cancer. Journal of Applied Social Psychology. 1999 Apr;29(4) :722-749.

Hudes G. Signaling inhibitors in the clinic: New agents and new challenges. Journal of Clinical Oncology. 1999 Apr;17(4) :1093-1094.

Kipling D, Wynford-Thomas D, Jones CJ, Akbar A, Aspinall R, Bacchetti S, Blasco MA, Broccoli D, DePinho RA, Edwards DR, Effros RB, Harley CB, Lansdorp PM, Linskens MHK, Prowse KR, Newbold RF, Olovnikov AM, Parkinson EK, Pawelec G, Ponten J, Shall S, Zijlmans M, Faragher RGA. Telomere-dependent senescence. Nature Biotechnology. 1999 Apr;17(4) :313-313.

Kedziera P. The two faces of pain... Office Nurse often adapts articles and news summaries that have appeared in RN and other sister journals. Office Nurse.. 1999 Apr;12(4) :13.

Chan AWS, Kukolj G, Skalka AM, Bremel RD. Timing of DNA integration, transgenic mosaicism, and pronuclear microinjection. Molecular Reproduction and Development. 1999 Apr;52(4) :406-413.

Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clinical Cancer Research. 1999 Apr;5(4) :775-782.

Colby TD, Vanderveen K, Strickler MD, Markham GD, Goldstein BM. Crystal structure of human type II inosine monophosphate dehydrogenase: Implications for ligand binding and drug design. Proceedings of the National Academy of Sciences of the United States of America. 1999 Mar 30;96(7) :3531-3536.

Bellacosa A, Cicchillitti L, Schepis F, Riccio A, Yeung AT, Matsumoto Y, Golemis EA, Genuardi M, Neri G. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7) :3969-74. PMC ID:PMC22404.

Cairns P, Sidransky D. Molecular methods for the diagnosis of cancer. Biochim Biophys Acta. 1999 Mar 25;1423(2) :C11-8.

Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, Flam MS, Sauter ER. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer. 1999 Mar 15;85(6) :1226-33.

Lobo A, Naso A, Arheart K, Kruger WD, Abou-Ghazala T, Alsous F, Nahlawi M, Gupta A, Moustapha A, van Lente F, Jacobsen DW, Robinson K. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B-6 and B-12. American Journal of Cardiology. 1999 Mar 15;83(6) :821-825.

Cheng CW, Das IJ. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH). International Journal of Radiation Oncology Biology Physics. 1999 Mar 15;43(5) :1143-1150.

Lattanzi J, McNeeley S, Pinover W, Horwitz E, Das I, Schultheiss TE, Hanks GE. A comparison of daily CT localization to a daily ultrasound- based system in prostate cancer. International Journal of Radiation Oncology Biology Physics. 1999 Mar 1;43(4) :719-725.

Ochs MF, Stoyanova RS, Arias-Mendoza F, Brown TR. A new method for spectral decomposition using a bilinear Bayesian approach. Journal of Magnetic Resonance. 1999 Mar;137(1) :161-176.

Clapper ML, Adrian RH, Pfeiffer GR, Kido K, Everley L, Cooper HS, Murthy S. Depletion of colonic detoxication enzyme activity in mice with dextran sulphate sodium-induced colitis. Alimentary Pharmacology & Therapeutics. 1999 Mar;13(3) :389-396.

Solin LJ, Schultz DJ, Kessler HB, Hanchak NA. Downstaging of Breast Carcinomas in Older Women Associated with Mammographic Screening. Breast J. 1999 Mar;5(2) :94-100.

Cheng JQ, Lee WC, Klein MA, Cheng GZ, Jhanwar SC, Testa JR. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation. Genes Chromosomes & Cancer. 1999 Mar;24(3) :238-242.

Taylor JM. Hepatitis delta virus. Intervirology. 1999 Mar-Jun;42(2-3) :173-178.

Lawrence DM, Vaughn MM, Belman AR, Cole JS, Rall GF. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J Virol. 1999 Mar;73(3) :1795-801.

Stevenson JP, DeMaria D, Sludden J, Kaye SB, Paz-Ares L, Grochow LB, McDonald A, Selinger K, Wissel P, O'Dwyer PJ, Twelves C. Phase I pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. Annals of Oncology. 1999 Mar;10(3) :339-344.

Bruner DW, Baffoe-Bonnie A, Miller S, Diefenbach M, Tricoli JV, Daly M, Pinover W, Grumet SC, Stofey J, Ross E, Raysor S, Balshem A, Malick J, Engstrom P, Hanks GE, Mirchandani I. Prostate cancer risk assessment program. A model for the early detection of prostate cancer. Oncology (Huntingt). 1999 Mar;13(3) :325-34; discussion 337-9, 343-4 pas.

Adler V, Yin ZM, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z. Regulation of JNK signaling by GSTp. Embo Journal. 1999 Mar 1;18(5) :1321-1334.

Buetow KH, Edmonson MN, Cassidy AB. Reliable identification of large numbers of candidate SNPs from public EST data. Nature Genetics. 1999 Mar;21(3) :323-325.

Manne SL, Pape SJ, Taylor KL, Dougherty J. Spouse support, coping, and mood among individuals with cancer. Annals of Behavioral Medicine. 1999 Spr;21(2) :111-121.

Gude RP, Binda MM, Presas HL, Klein-Szanto AJP, Bonfil RD. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline. Journal of Biomedical Science. 1999 Mar-Apr;6(2) :133-141.

Hanks GE. Ten-year disease free survival after transperineal sonography- guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma. Cancer. 1999 Mar 1;85(5) :1204-1205.

Grammatikakis N, Lin JH, Grammatikakis A, Tsichlis PN, Cochran BH. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. Molecular and Cellular Biology. 1999 Mar;19(3) :1661-1672.

Schalk-Hihi C, Markham GD. The conformations of a substrate and a product bound to the active site of S-adenosylmethionine synthetase. Biochemistry. 1999 Feb 23;38(8) :2542-2550.

Oleykowski CA, Bronson Mullins CR, Chang DW, Yeung AT. Incision at nucleotide insertions/deletions and base pair mismatches by the SP nuclease of spinach. Biochemistry. 1999 Feb 16;38(7) :2200-5.

Allman D, Li J, Hardy RR. Commitment to the B lymphoid lineage occurs before DH-JH recombination. J Exp Med. 1999 Feb 15;189(4) :735-40.

Gary R, Kim K, Cornelius HL, Park MS, Matsumoto Y. Proliferating cell nuclear antigen facilitates excision in long-patch base excision repair. Journal of Biological Chemistry. 1999 Feb 12;274(7) :4354-4363.

Morgan RO, Bell DW, Testa JR, Fernandez MP. Human annexin 31 genetic mapping and origin. Gene. 1999 Feb 4;227(1) :33-38.

Murthy S, Cooper HS, Yoshitake H, Meyer C, Meyer CJ, Murthy NS. Combination therapy of pentoxifylline and TNF alpha monoclonal antibody in dextran sulphate-induced mouse colitis. Alimentary Pharmacology & Therapeutics. 1999 Feb;13(2) :251-260.

Siegelmann-Danieli N, Buetow KH. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. British Journal of Cancer. 1999 Feb;79(3-4) :456-463.

Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: A predictor for late radiation morbidity. International Journal of Radiation Oncology Biology Physics. 1999 Feb 1;43(3) :475-479.

Rankin SE, Watts A, Roder H, Pinheiro TJT. Folding of apocytochrome c induced by the interaction with negatively charged lipid micelles proceeds via a collapsed intermediate state. Protein Science. 1999 Feb;8(2) :381-393.

Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Gemcitabine and carboplatin in combination: An update of phase I and phase II studies in non-small cell lung cancer. Seminars in Oncology. 1999 Feb;26(1) :12-18.

Williams M, Lyu MS, Yang YL, Lin EP, Dunbrack R, Birren B, Cunningham J, Hunter K. Ier5, a novel member of the slow-kinetics immediate-early genes. Genomics. 1999 Feb 1;55(3) :327-334.

Das IJ, Cheng CW, Akber SF. Low monitor units: significance in special therapy. Physics in Medicine and Biology. 1999 Feb;44(2) :L1-L2.

Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma - Prognostic features and natural history. American Journal of Clinical Oncology-Cancer Clinical Trials. 1999 Feb;22(1) :22-28.

Huang Y, Bove B, Wu Y, Russo IH, Yang X, Zekri A, Russo J. Microsatellite instability during the immortalization and transformation of human breast epithelial cells in vitro. Mol Carcinog. 1999 Feb;24(2) :118-27.

Boente MP. Oncology. Ovarian cancer: surgical aspects of patient care. Journal of Care Management.. 1999 Feb;5(1) :Disease Manage Digest: 4-5.

Weiner LM. Paclitaxel in the treatment of esophageal cancer. Seminars in Oncology. 1999 Feb;26(1) :106-108.

Ozols RF. Paclitaxel plus carboplatin in the treatment of ovarian cancer. Seminars in Oncology. 1999 Feb;26(1) :84-89.

Russo J, Ao X, Grill C, Russo IH. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Research and Treatment. 1999 Feb;53(3) :217-227.

Yang YL, Guo L, Xu SA, Holland CA, Kitamura T, Hunter K, Cunningham JM. Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nature Genetics. 1999 Feb;21(2) :216-219.

Orlow SJ, Brilliant MH. The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye. Experimental Eye Research. 1999 Feb;68(2) :147-154.

Thrash-Bingham CA, Tartof KD. aHIF: A natural antisense transcript overexpressed in human renal cancer and during hypoxia. Journal of the National Cancer Institute. 1999 Jan 20;91(2) :143-151.

Matsuda T, Terashima I, Matsumoto Y, Yabushita H, Matsui S, Shibutani S. Effective utilization of N-2-ethyl-2 '-deoxyguanosine triphosphate during DNA synthesis catalyzed by mammalian replicative DNA polymerases. Biochemistry. 1999 Jan 19;38(3) :929-935.

Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A 3rd. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). Cancer. 1999 Jan 15;85(2) :290-4.

Balsara BR, Bell DW, Sonoda G, De Rienzo A, du Manoir S, Jhanwar SC, Testa JR. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Research. 1999 Jan 15;59(2) :450-454.

Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: Patterns of care study. International Journal of Radiation Oncology Biology Physics. 1999 Jan 15;43(2) :351-358.

Smitt MC, Stouffer N, Owen JB, Hoppe RT, Hanks GE. Results of the 1988-1989 patterns of care study process survey for Hodgkin's disease. International Journal of Radiation Oncology Biology Physics. 1999 Jan 15;43(2) :335-339.

Matsumoto Y. Base excision repair assay using Xenopus laevis oocyte extracts. Methods Mol Biol. 1999 ;113 :289-300.

Hamilton TC, Berek JS, Kaye SB. Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?. Annals of Oncology. 1999 ;10 :69-73.

Russo J, Russo IH. Cellular basis of breast cancer susceptibility. Oncology Research. 1999 ;11(4) :169-178.

Garay CA, Engstrom PF. Chemoprevention of colorectal cancer: Dietary and pharmacologic approaches. Oncology-New York. 1999 Jan;13(1) :89-97.

Dunbrack RL. Comparative modeling of CASP3 targets using PSI-BLAST and SCWRL. Proteins-Structure Function and Genetics. 1999 :81-87.

Pear W, Tang Z, DeRocco S, Allman D, Hardy R, Pui J, Xu L, Karnell F, Aster J, Kadesch T. Consequences of Notch-mediated inhibition of the transcription factor E47. Cold Spring Harbor Symposia on Quantitative Biology. 1999 ;64 :33-38.

Rogatko A, Babb J, Jordan H, Zacks S. Constructing meiotic maps with known error probability. Genetic Epidemiology. 1999 ;16(3) :274-289.

Pulfer SK, Ciccotto SL, Gallo JM. Distribution of small magnetic particles in brain tumor-bearing rats. Journal of Neuro-Oncology. 1999 Jan;41(2) :99-105.

Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology. 1999 Jan;18(1) :14-20.

Bookman MA. Extending the platinum-free interval in recurrent ovarian cancer: the role of topotecan in second-line chemotherapy. Oncologist. 1999 ;4(2) :87-94.

Cooper KF, Strich R. Functional analysis of the Ume3p/Srb11p-RNA polymerase II holoenzyme interaction. Gene Expression. 1999 ;8(1) :43-57.

Abdollahi A, Getts LA, Sonoda G, Miller PD, Taguchi T, Godwin AK, Testa JR, Hamilton TC. Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells. Journal of the Society for Gynecologic Investigation. 1999 Jan-Feb;6(1) :32-40.

Hirai H, Taguchi T, Godwin AK. Genomic differentiation of 18S ribosomal DNA and beta-satellite DNA in the hominoid and its evolutionary aspects. Chromosome Research. 1999 ;7(7) :531-540.

Boente MP, Schilder R, Ozols RF. Gynecological cancers. Cancer Chemother Biol Response Modif. 1999 ;18 :418-34.

Asante-Appiah E, Skalka AM. HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv Virus Res. 1999 ;52 :351-69.

Mello MLS, Vidal BD, Russo J. Ha-ras oncogene effect on DNA content and chromatin supraorganization in benzo a pyrene-transformed human breast epithelial cells. Analytical Cellular Pathology. 1999 ;19(2) :73-79.

Chen P, Poddar R, Tipa EV, Dibello PM, Moravec CD, Robinson K, Green R, Kruger WD, Garrow TA, Jacobsen DW. Homocysteine metabolism in cardiovascular cells and tissues: Implications for hyperhomocysteinemia and cardiovascular disease. Advances in Enzyme Regulation, Vol 39. 1999 ;39 :93-109.

Taylor JM. Human hepatitis delta virus: an agent with similarities to certain satellite RNAs of plants. Curr Top Microbiol Immunol. 1999 ;239 :107-22.

Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. Hypoxic regions exist in human prostate carcinoma. Urology. 1999 Jan;53(1) :11-18.

Ozols RF, Gore M, Trope C, Grenman S. Intraperitoneal treatment and dose-intense therapy in ovarian cancer. Annals of Oncology. 1999 ;10 :59-64.

Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer. Acta Oncologica. 1999 ;38 :9-17.

Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?. Radiation Oncology Investigations. 1999 ;7(4) :249-259.

Algan O, Pinover WH, Hanlon AL, Al-Saleem TI, Hanks GE. Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?. Radiat Oncol Investig. 1999 ;7(2) :106-10.

Glusker JP, Katz AK, Bock CW. Metal ions in biological systems. The Rigaku Journal. 1999 ;16 :8-16.

Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold BS. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes. 1999 Jan;48(1) :198-202.

Townsend AJ, Fields WR, Doss AJ, Clapper ML, Doehmer J, Morrow CS. Modeling the chemoprotective functions of glutathione S- transferases in cultured cell lines by heterologous expression. Drug Metabolism Reviews. 1999 ;31(1) :43-69.

Kaye SB, Eisenhauer EA, Hamilton TC. New non-cytotoxic approaches to ovarian cancer. Annals of Oncology. 1999 ;10 :65-68.

Ozols RF. Oral etoposide for the treatment of recurrent ovarian cancer. Drugs. 1999 ;58 Suppl 3 :43-9.

Gumbiner LM, Gumerlock PH, Mack PC, Chi SG, deVere White RW, Mohler JL, Pretlow TG, Tricoli JV. Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate. 1999 Jan 1;38(1) :40-5.

Meropol NJ, Rustum YM, Creaven PJ, Blumenson LE, Frank C. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: A potential role for growth factor as mucosal protectant. Cancer Investigation. 1999 ;17(1) :1-9.

Yang NCC, Zhang SL, Lang MJ, Goodman S, Durnell C, Fleming GR, Carrell HL, Garavito RM. Photoinduced electron transfers through sigma bonds in solution. Electron Transfer-from Isolated Molecules to Biomolecules, Pt 1. 1999 ;106 :645-666.

Rani DBR, Bayer ME, Schifferli DM. Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria. Clinical and Diagnostic Laboratory Immunology. 1999 Jan;6(1) :30-40.

Juo SHH, Pugh EW, Baffoe-Bonnie A, Kingman A, Sorant AJM, Klein AP, O'Neill J, Mathias RA, Wilson AF, Bailey-Wilson JE. Possible linkage of alcoholism, monoamine oxidase activity and p300 amplitude to markers on chromosome 12q24. Genetic Epidemiology. 1999 ;17 :S193-S198.

Hanks GE. Progress in 3D conformal radiation treatment of prostate cancer. Acta Oncologica. 1999 ;38 :69-74.

Cerda SR, Wilkinson J, Thorgeirsdottir S, Broitman SA. R-(+)-perillyl alcohol-induced cell cycle changes, altered actin cytoskeleton, and decreased ras and p34(cdc2) expression in colonic adenocarcinoma SW480 cells. Journal of Nutritional Biochemistry. 1999 Jan;10(1) :19-30.

Mello MLS, Barbisan LF, Russo J, Vidal BD. RNA relocation at mitosis in transformed and tumorigenic human breast epithelial cells. Cell Biology International. 1999 ;23(2) :125-128.

Taylor JM. Replication of human hepatitis delta virus: influence of studies on subviral plant pathogens. Adv Virus Res. 1999 ;54 :45-60.

Sigal EV. Report from the March research task force - Commissioned by THE MARCH - Coming together to conquer cancer. Stem Cells. 1999 ;17(6) :382-419.

Lee WC, Testa JR. Somatic genetic alterations in human malignant mesothelioma (Review). International Journal of Oncology. 1999 Jan;14(1) :181-188.

Glusker JP, Carrell HL, Katz AK, Afshar CE. Structural studies of PAHs and their metabolites. Polycyclic Aromatic Compounds. 1999 ;14 :87-98.

Katzman M, Katz RA. Substrate recognition by retroviral integrases. Advances in Virus Research, Vol 52. 1999 ;52 :371-395.

McGuire WP, Brady MF, Ozols RF. The Gynecologic Oncology Group experience in ovarian cancer. Annals of Oncology. 1999 ;10 :29-34.

Glusker JP. The binding of ions to proteins. Proteins - A Comprehensive Treatise. 1999 ;2 :99-152 (Ch. 4).

Miknyoczki SJ, Dionne CA, Klein-Szanto AJP, Ruggeri BA. The novel Trk receptor tyrosine-kinase inhibitor CEP-701 (KT- 5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness. Cell and Molecular Biology of Pancreatic Carcinoma: Recent Developments in Research and Experimental Therapy. 1999 ;880 :252-262.

Langer CJ. The role of tegafur/uracil in pulmonary malignancy. Drugs. 1999 ;58 Suppl 3 :71-5.

Golemis EA, Serebriiskii I, Law SF. The yeast two-hybrid system: criteria for detecting physiologically significant protein-protein interactions. Curr Issues Mol Biol. 1999 ;1(1-2) :31-45.

1999 (295 publications)